4d Pharma Plc

4d Pharma (DDDD)

Buy
Sell
Company name:4d Pharma Plc
EPIC:DDDDTrading Currency:GBX
Market Sector:ASM6ISIN:GB00BJL5BR07
Market Segment:AMSMShare Type:DE
WWW Address:http://www.4dpharmaplc.com/Description:ORD 0.25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 114.50 images.advfn.com/imagesnew/2/gb/down -7.5 [-6.15] 114.00 115.00 125.00 125.00 110.50 3,094,542
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 150.44 131.39 -0.30 -36.75 - - - 183.00 - 23.50

4d Pharma Key Figures

(at previous day's close)
Market Cap.150.44m
Shares In Issue131.39m
Prev. Close122.00
PE Ratio- 
Dividend Yield-%
EPS - basic-36.75p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-16.41p
Return On Equity (ROE)-106.02%
Operating Margin-%
PEG Factor- 
EPS Growth Rate-1.60%
Dividends PS Growth Rate-%
Net Debt4.43m
Gross Gearing27.01%
Quick Assets11.26m
Net Working Capital5.20m
Intangibles / Fixed Assets73.05%
Turnover PS-p
Pre-Tax Profit PS-22.40p
Retained Profit PS-18.03p
Cash PS2.92p
Net Cash PS-1.84p
Net Tangible Asset Value PS *6.36p
Net Asset Value PS17.00p
Spread1.00 (0.87%) 

4d Pharma Balance Sheet

LSE:DDDD:Liabilities+EQLSE:DDDD:Assets

Share Price Performance

Sample Period HighLow
1 week143.5088.00
4 weeks183.0088.00
12 weeks183.0048.00
1 year183.0023.50

Share Price Chart (5 years)

4d Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week102.0012.5012.2588.006.81118.45
4 weeks163.00-48.50-29.7588.006.44115.16
12 weeks52.8061.70116.8648.004.51112.28
26 weeks57.0057.50100.8835.603.5387.41
1 year97.5017.0017.4423.502.0884.97
3 years365.00-250.50-68.6323.500.7787.37
5 years765.00-650.50-85.0323.500.48101.32

4d Pharma Key Management Ratios

4d Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 3.62 
Tobin's Q Ratio (excl. intangibles)5.49 
Dividend Yield-%
Market-to-Book Ratio6.73 
Price-to-Pre-Tax Profit PS-5.11 
Price-to-Retained Profit PS-6.35 
Price-to-Cash Flow PS-6.98 
Price-to-Sales PS- 
Price-to-Net Tangible Asset Value PS18.01 
Price-to-Cash PS39.22 
Net Working Capital PS3.96 
Price Pct to Working Capital PS28.92%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

4d Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio8.24%
Debt-to-Equity Ratio0.09 
Debt-to-Equity Ratio (excl. Intgbl)0.24 
Debt-to-Equity Market Value0.01 
Net Gearing14.48%
Net Gearing (excl. Intangibles)26.66%
Gross Gearing27.01%
Gross Gearing (excl. Intangibles)49.74%
Gearing Under 1 Year20.45%
Gearing Under 1 Year (excl. Intgbl)37.66%
Assets/Equity1.37 
Cash/Equity17.17 
(Liquidity Ratios)
Net Working Capital to Total Assets16.99%
Current Ratio1.83 
Quick Ratio (Acid Test)1.80 
Liquidity Ratio0.61 
Cash & Equiv/Current Assets33.47%
(Solvency Ratios)
Enterprise Value148.62m
CFO/Sales- 
CFO/Attributable Profit- 
CFO/Assets-0.70 
CFO/Debt-2.61 
Total Debt/Equity Market Value0.05 
Total Debt/Sales- 
Total Debt/Pre-Tax Profit-0.28 
Total Debt8.27m
Total Debt/Net Current Assets1.59%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
-0.30050.1142

4d Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-120.85%
Return On Assets (ROA)-56.93%
Net Profit Margin-%
Assets Turnover- 
Return On Equity (ROE)-106.02%
Return On Investment (ROI)-66.00%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-%
(Asset Utilisation Multiples)
Shareholders Equity Turnover- 
Fixed Assets Turnover- 
Current Assets Turnover- 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales- 
Debtors-to-Sales-%
Debt Collection Period-Days

4d Pharma Dividends

Sorry No Data Available

4d Pharma Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
turnover--------m
pre tax profit-11.71--23.99--28.44--29.43-m
attributable profit-10.25--19.39--24.29--23.69-m
retained profit-10.25--19.39--24.29--23.69-m
eps - basic (p)-15.21 -31.41 -36.17 -36.75 
eps - diluted (p)-15.21 -31.41 -36.17 -36.75 
dividends per share- - - - 

4d Pharma Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
LSE:DDDD:Liabilities+EQLSE:DDDD:AssetsLSE:DDDD:Liabilities+EQLSE:DDDD:AssetsLSE:DDDD:Liabilities+EQLSE:DDDD:AssetsLSE:DDDD:Liabilities+EQLSE:DDDD:Assets
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
ASSETS
fixed assets fixed assets3.864.14%5.216.70%4.879.25%5.1616.86%m
intangibles intangibles14.3015.35%14.6718.88%14.4527.46%13.9945.70%m
fixed investments fixed investments40.1143.06%38.1349.05%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.240.26%0.250.33%0.290.55%0.200.65%m
debtors debtors5.996.43%7.609.78%16.9532.23%7.4324.27%m
cash & securities cash & securities28.6630.77%11.8715.26%16.0530.52%3.8412.53%m
TOTAL93.16100%77.74100%52.61100%30.61100%m
LIABILITIES
creditors - short creditors - short4.945.30%4.986.41%5.189.84%6.2620.45%m
creditors - long creditors - long1.741.86%2.973.82%1.673.17%2.016.56%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL6.677.16%7.9510.23%6.8413.01%8.2727.01%m
EQUITY
ord cap, reserves ord cap, reserves86.4892.84%69.7989.77%45.7686.99%22.3472.99%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL86.4892.84%69.7989.77%45.7686.99%22.3472.99%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

4d Pharma Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-13.53-17.19-22.94-21.56m
Pre-Financing CF26.88-16.784.20-11.84m
Retained CF26.88-16.804.19-12.22m

4d Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
DDDD
4d Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201027 13:51:58